Tejas Dhameliya, Author at Institute of Pharmacy
Institute of Management, Nirma University - Logo
 Tejas Dhameliya

Tejas Dhameliya

Educational Qualification

    Ph.D., M.S.(Pharm.), B.Pharm.

Research Area

    Heterocyclic chemistry, Molecular Modeling, Computer Aided Drug Design (CADD), Anti-tubercular and anti-malarial drug discovery


  • Assistant Professor


  • Pharmaceutical Chemistry

General Information

  • 07971652729

  • 102, Faculty Office, Department of Pharmaceutical Chemistry, Institute of Pharmacy, Nirma University, Sarkhej Gandhinagar Highway, Ahmedabad, Gujarat-382481, India


    Synthetic Medicinal Chemistry


  • Dr. Tejas M. Dhameliya has completed B. Pharm. From L. M. College of Pharmacy (LMCP), Ahmedabad in 2012 and M.S. (Pharm.) from Department of Medicinal Chemistry in June 2014 from National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, India. During his M.S. (Pharm.). He carried out his project work under the direct supervision of Prof. Asit K. Chakraborti on "Design and Synthesis of Novel Benzothiazoles as Potential Anti-tubercular Agents". His thesis has been awarded at National level by the award of Rajnibhai V. Patel PharmInnova Award for the most "Innovative Thesis" in M. Pharm. (Pharmaceutical Chemistry) category in Pharmaceutical Sciences 2014-15 jointly organized by Troikaa Pharmaceutical Ltd., Ahmedabad; Department of Science and Technology (DST), New Delhi and LMCP, Ahmedabad. Later, he joined as a Ph.D. research scholar under the guidance of Prof. Asit K. Chakraborti in July 2014 in NIPER, S.A.S. Nagar to pursue his career in research and drug discovery. He has worked as Asst. Prof. at LMCP, Ahmedabad during Aug 2017 to Jan 2023 and moved to Institute of Pharmacy, Nirma University, Ahmedabad in Jan 2023. With h-index of 16, i-10 index of 19, he has published a total of 18 research and 16 review articles in international peer reviewed journals of high impact, and filed two Indian patents, and guided seven M.Pharm. students for their dissertations. He has been the recipient of financial assistance to attend ACS Fall 2022 held in Chicago (USA) during Aug 21-25, 2022 through International Travel Support (ITS) from DST-Science Engineering Research Board (SERB). He has also received a total of eight grants of worth 5.15 Lakh rupees from Student Start-up Innovation Policy (SSIP), Gujarat. His area for research includes development of anti-TB, anti-cancer agents and SARS CoV-2 inhibitors using green methodologies of synthesis adopting water, nano-particles and ionic liquid; molecular modeling such as 3D-QSAR, docking, molecular dynamics simulations and quantum chemical calculations or density functional theory.